Efficacy of pd-1/pd-l1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis

HIGHLIGHTS

• who: Gengwei Huo from the Department of Thoracic Oncology, Tianjin Medical University Research Center for, Tianjin, China have published the Article: Efficacy of PD-1/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis, in the Journal: (JOURNAL)
• what: When the authors focused on PS 0 and 1, the findings showed that patients with PS 1 seemed to have a longer survival benefit for the treatment of anti-PD-1/anti-PD-L1, with an HR, of 0.93 for patients with PS 0 and 0.89 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.